LBRX LB PHARMACEUTICALS INC
Nasdaq · SEC CIK 1691082 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 27 since 2025-09-12, latest 2026-08-03 19:28
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 9
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-16 | 2025-09-12 | LBRX | Deep Track Capital, LP | 10% | C - Cnv Deriv | — | +686.1K | 686.1K | New | — |
| D | 2025-09-16 | 2025-09-12 | LBRX | Deep Track Capital, LP | 10% | P - Purchase | $15.00 | +2.00M | 2.69M | +291% | +$30.00M |
| DI | 2025-09-16 | 2025-09-12 | LBRX | Deep Track Capital, LP | 10% | P - Purchase | $15.00 | +666.7K | 666.7K | New | +$10.00M |
| DMI | 2025-09-16 | 2025-09-12 | LBRX | Vida Ventures GP III, L.L.C. | 10% | P - Purchase | $15.00 | +333.3K | 2,029 | New | +$5.00M |
| DMI | 2025-09-16 | 2025-09-12 | LBRX | Vida Ventures GP III, L.L.C. | 10% | C - Cnv Deriv | — | +548.9K | 1,262 | New | — |
| DI | 2025-09-16 | 2025-09-12 | LBRX | Pontifax Management 4 G.P. (2015) Ltd. | 10% | C - Cnv Deriv | — | +411.7K | 411.7K | New | — |
| DI | 2025-09-16 | 2025-09-12 | LBRX | Pontifax Management 4 G.P. (2015) Ltd. | 10% | P - Purchase | $15.00 | +1.00M | 1.41M | +243% | +$15.00M |
| DI | 2025-09-16 | 2025-09-12 | LBRX | Nussbaum Ran | Dir | C - Cnv Deriv | — | +411.7K | 411.7K | New | — |
| DI | 2025-09-16 | 2025-09-12 | LBRX | Nussbaum Ran | Dir | P - Purchase | $15.00 | +1.00M | 1.41M | +243% | +$15.00M |
Purchase Sale Sale after option exercise All abbreviations